Drug profile · INN
amlodipine besylate
AMLODIPINE BESYLATE
amlodipine besylate (AMLODIPINE BESYLATE) is a voltage-gated l-type calcium channel blocker. Associated with PURPLE BIOTECH LTD.. Route of administration: oral. Current US regulatory status: approved.
Drug details — amlodipine besylate
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 20
- Programs
- 15
- Data quality
- 0.89
Quick answer
amlodipine besylate (AMLODIPINE BESYLATE) is a voltage-gated l-type calcium channel blocker. Associated with PURPLE BIOTECH LTD.. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Voltage-gated L-type calcium channel blocker
Primary target: Voltage-gated L-type calcium channel
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Related patents
-
US 12384779
Bicyclic compounds
granted -
US 12180192
Modulators of THR-β and methods of use thereof
granted -
US 12018015
Methods and compositions for targeting PD-L1
granted -
US 11957683
Bicyclic compounds
granted -
US 11952374
Bicyclic compounds
granted -
US 11939581
Methods and compositions for targeting PD-L1
granted -
US 11858913
Bicyclic pyridazinones and methods of use thereof
granted -
US 11840532
Modulators of THR-β and methods of use thereof
granted -
US 11820773
Tricyclic compounds
granted -
US 11793815
Oxindoles and methods of use thereof
granted -
US 11786532
2-pyridones and methods of use thereof
granted -
US 11771680
Pyrrole compounds
granted -
US 11760764
Methods and compositions for targeting PD-L1
granted -
US 11760761
Methods and compositions for targeting PD-L1
granted -
US 11752184
Bioactive concentrates and uses thereof
granted -
US 11613750
Methods of reducing virus molecule levels
granted -
US 11591341
Bicyclic and tricyclic compounds
granted -
US 11464783
Heterocyclic compounds
granted -
US 11198699
Compounds targeting PRMT5
granted -
US 11191747
Pyrrole compounds
granted
Frequently asked questions
What is amlodipine besylate?
amlodipine besylate (AMLODIPINE BESYLATE) is a voltage-gated l-type calcium channel blocker. Associated with PURPLE BIOTECH LTD.. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for amlodipine besylate?
AMLODIPINE BESYLATE is a marketed brand name for amlodipine besylate. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of amlodipine besylate?
amlodipine besylate has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.